Aminoglutethimide, an inhibitor of adrenal steroidogenesis, blocks heart growth after ligation of the abdominal aorta and in hyperthyroidism in rats
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
6219405
Knihovny.cz E-zdroje
- MeSH
- aminoglutethimid farmakologie MeSH
- aorta abdominalis chirurgie MeSH
- hypertyreóza patofyziologie MeSH
- inbrední kmeny potkanů MeSH
- kardiomegalie etiologie MeSH
- krysa rodu Rattus MeSH
- methylthiouracil farmakologie MeSH
- srdce účinky léků patofyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- aminoglutethimid MeSH
- methylthiouracil MeSH
With reference to the indirect evidence showing that heart growth in the presence of a cardiac overload is modulated by the adrenal cortex, we studied heart reactions to overloading (ligation of the abdominal aorta or hyperthyroidism) with simultaneous administration of aminoglutethimide, an inhibitor of steroidogenesis. Aminoglutethimide (Elipten CIBA, 0.5% in the diet) markedly inhibited the growth reaction of the heart 14 days after ligation of the abdominal aorta (reducing the aortal blood flow to about 40%) or after the administration of dried thyroid (Thyreoidin SPOFA, 0.2% in the diet). The effect of aminoglutethimide is evidently not due to its simultaneous antithyroid action, because methylthiouracil (Alkiron SPOFA, 0.2% in the diet) did not limit heart growth after ligation of the abdominal aorta, despite its having a stronger goitrogenic effect than aminoglutethimide. The results are a further contribution to the series of indirect evidence of the modulating effect of the adrenal cortex on heart growth.